DocGo Inc
NASDAQ:DCGO
DocGo Inc
Research & Development
DocGo Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
D
|
DocGo Inc
NASDAQ:DCGO
|
Research & Development
-$10.9m
|
CAGR 3-Years
-108%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
DaVita Inc
NYSE:DVA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is DocGo Inc's Research & Development?
Research & Development
-10.9m
USD
Based on the financial report for Dec 31, 2023, DocGo Inc's Research & Development amounts to -10.9m USD.
What is DocGo Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-108%
Over the last year, the Research & Development growth was -101%. The average annual Research & Development growth rates for DocGo Inc have been -108% over the past three years .